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Background: The few published studies comparing results between commercial red-cell folate immunoassays have
found significant differences. None have provided longitudinal data during the development of megaloblastic
anaemia from severe folate deficiency. The objective was to produce longitudinal data, comparing results between
three commercial immunoassays for red-cell folate, generated by means of severe experimental folate deficiency.
Methods: This 58 year old male, initially replete in folate, used a folate-deficient diet to severely deplete himself of
folate until overt megaloblastic anaemia developed. The Siemens Advia Centaur, Roche Elecsys 2010 and Beckman
UniCel DxI 800 Access immunoassay systems were used, by different clinical pathology laboratories, to perform
weekly assays for red-cell folate throughout the depletion stage. The results were analysed graphically four ways:
comparison with lines of equality; number of standard deviations difference against the means; number of standard
deviations difference over time; variation over time.
Results: There were very significant differences, varying with time and folate concentration, between the results reported
by the three laboratories. The differences were greatest, up to 17 standard deviations, between the Siemens Advia
Centaur and each of the other two systems. Of the 85 results comparing the Siemens Advia Centaur and the Roche
Elecsys 2010, two were within the 99.9% confidence interval. Of the 91 results comparing the Siemens Advia Centaur and
the Beckman UniCel DxI 800 Access, 22 were within the 99.9% confidence interval. Of the 83 results comparing the
Beckman UniCel DxI 800 Access and the Roche Elecsys 2010, 37 were within the 99.9% confidence interval.
Conclusions: Comparative longitudinal data from clinical pathology laboratories, produced during experimental folate
deficiency, have exposed very significant differences in results between commercial red-cell folate immunoassays. One
immunoassay, the Roche Elecsys 2010, failed to detect overt megaloblastic anaemia of severe folate deficiency.
Keywords: Red-cell folate immunoassays; Immunoassay errors; Megaloblastic anaemia; Diagnosis of folate deficiencyBackground
Folate deficiency increases the risk of anaemia, neural
tube defects, cancer, vascular disease and neurological
disorders (Bailey 1995, 2009). In addition to dietary in-
adequacy, a functional folate deficiency can be caused by
anything that interferes with the bioavailability of the
folate, including any defect in the hydrolysis, absorption,
transport or cellular utilization (McNulty and Pentieva
2009; Gregory 1995). Folate antagonists include alcohol,Correspondence: paul@paulgolding.id.au
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© 2014 Golding; licensee Springer. This is an O
Attribution License (http://creativecommons.or
in any medium, provided the original work is pand medicines used for the treatment of cancer, rheu-
matoid arthritis, inflammatory bowel disease and other
disorders (McNulty and Pentieva 2009; Gregory 1995).
Gastro-intestinal disease or mutations in genes for folate
transport or metabolism also affect folate bioavailability
(McNulty and Pentieva 2009). A deficiency of vitamin
B12 can cause a secondary, functional, folate deficiency
by means of the methylfolate trap (Tisman and Herbert
1973; Smulders et al. 2006; Scott and Weir 1981).
Because a folate-replete diet cannot guarantee adequate
folate bioavailability, even where there is mandatory foodpen Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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ical pathology tests for folate. Microbiological assays and
mass spectrometry methods are not routinely used outside
of the research environment. Because of their lower cost
and higher throughput, commercial automated immuno-
assays are used for routine patient testing (Pfeiffer et al.
2009).
Published studies have reported significant differences
in folate results between methods (Nakazato et al. 2012;
Clifford et al. 2005; Gunter et al. 1996; Jacobsen 1996;
Callen 2010; Owen and Roberts 2003). There have been
calls for the standardization of reference intervals for
red-cell folate, to allow results to be compared between
laboratories and to establish minimum safe concentra-
tions. In reporting the results of an international method
comparison study, Gunter (1996) concluded: “The over-
all results underscore the urgent need for developing and
validating reference methods for serum and whole-blood
folate and for properly characterized reference materials”.
In a related editorial, Jacobsen (1996) stated: “A task
force should be established and given the charge of trou-
bleshooting folate assay problems and establishing refer-
ence methods”. Wright et al. (1998) stated: “Assessment
of the assumptions that underpin RCF assays indicates
that many are false”.
Despite these calls for change, the problems with the
assay of red-cell folate, in a clinical setting, remain. Clifford
(2005) reported: “We conclude that RBC folate levels are
assay dependent, as is the definition of optimized status;
there continues to be a need for an accurate assay of RBC
folate”. Wickramasinghe (2006) stated: “The accuracy of
folate assays and particularly of fully-automated red cell
folate assays is questionable.” According to Pfeiffer et al.
(2009): “much more needs to be done to achieve better com-
parability between methods”.
Two published studies compared the three commercial
automated red-cell folate immunoassay systems used in
this experiment; Siemens Advia Centaur, Roche Elecsys
2010 and Beckman UniCel DxI 800 Access (Callen 2010;
Owen and Roberts 2003). According to Callen, these
three systems account for 61% of instruments used for
assay of red-cell folate in Australia. Both studies reported
significant differences between results for the three sys-
tems. There is no published longitudinal data comparing
immunoassay methods, in a clinical setting, during the de-
velopment of severe folate deficiency.
In 2009, while performing a self-experiment to investi-
gate tests for vitamin B12 deficiency, this author moni-
tored his folate concentrations to check for the possibility
of secondary, functional, folate deficiency caused by the
methylfolate trap (Tisman and Herbert 1973; Smulders
et al. 2006; Scott and Weir 1981).
The three red-cell folate immunoassay systems pro-
duced very significantly different results, (unpublisheddata, available from this author). Repeated testing, with
samples collected within a two-hour window, produced
results from one system that were three times the red-
cell folate concentration reported by another. Because
these three systems account for 61% of instruments used
for assay of red-cell folate in Australia (Callen 2010),
and one system alone accounts for 33%, such errors
could affect many patients.
Because pregnancy increases the demand for folate,
and because of the risk of neural-tube defects in children
of folate-deficient mothers, significant errors in the
measurement of red-cell folate could have very serious
consequences. Other patients at high risk of folate defi-
ciency, including those taking specific medicines or with
gastro-intestinal disease or certain genetic disorders,
could also suffer serious harm.
Commencing in May 2011, this author used himself
as the subject of an experiment to investigate the dis-
crepancies between the three red-cell folate immunoas-
says, the subject of this report. The biochemical and
haematological responses to the resulting severe folate
deficiency have been described in detail in a separate
report (Golding 2014).
Objectives
The objective of this investigation was to produce longitu-
dinal data, comparing results between three commercial
immunoassays for red-cell folate, generated by means of
severe experimental folate deficiency.
Methods
Ethics statement
As a member of COPE (Committee on Publication
Ethics), SpringerPlus requires that experiments on hu-
man subjects adhere to the ethical standards of the
Declaration of Helsinki. In particular, there must be in-
formed consent of subjects, and the experiment must
be approved and overseen by a research ethics com-
mittee or institutional review board. Because this au-
thor did not obtain informed consent, and the study
did not receive ethics committee approval, it is neces-
sary for the author to explain the reasons why publica-
tion of this report is ethical.
Firstly, the author was both the experimenter and the
single subject, so the requirement for informed consent
does not apply. There was no institutional involvement,
so there was no possibility of coercion. The subject was
assessed by a psychiatrist before the experiment com-
menced, and found to be competent to evaluate the risks
and benefits, and to accept full responsibility for the
conduct of the experiment.
Secondly, the Declaration of Helsinki is silent on self-
experimentation, because it is concerned with the con-
duct of research on patients or healthy volunteers by
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therefore does not apply where the single subject is also
the sole experimenter. Also, because there was no institu-
tion involved in the study, with the experiment conducted
by an independent researcher, no ethics committee existed.
Thirdly, the experiment was not performed reck-
lessly or carelessly; the subject’s condition was moni-
tored weekly by the psychiatrist. This doctor is a
Fellow of the Royal Australian and New Zealand College
of Psychiatrists, and had no conflict of interests. Being a
qualified medical practitioner receiving all weekly path-
ology reports, he was able to continually assess the condi-
tion of the subject. For safety, it was agreed at the outset
that he would take control if, but only if, there was an im-
mediate life-threatening condition. The subject instigated,
designed and performed the experiment, and this doctor’s
only role was monitoring for safety.
Lastly, the motivation for performing the experiment
was ethical, and involved no conflict of interests. The
author wanted to investigate the gross differences be-
tween the red-cell folate immunoassays, as found during
his experiment of 2009, because he was aware of the po-
tential consequences of errors in measurement of folate
concentrations, especially in pregnant women and others
at high risk of deficiency. The author was motivated only
by the desire to gain and share knowledge, to advance
medical science, for the benefit of patients.
Experiment design
A human subject, initially replete in folate, consumed a
folate-deficient diet to severely deplete the body of fol-
ate, culminating in megaloblastic anaemia. Precautions
were taken to avoid the confounding effects of other nu-
trient deficiencies. The biochemical and haematological
responses were monitored by weekly or twice-weekly
blood tests during both the depletion and recovery
stages. Three commercial clinical pathology laboratories,
all accredited by the Australian National Association of
Testing Authorities (NATA), were used to increase con-
fidence in the results. One research laboratory, specializ-
ing in microbiological folate assays, was used to confirm
severe folate depletion of the subject. Megaloblastic an-
aemia was confirmed by blood cell counts, blood films,
and bone marrow examination.
The subject
The subject was this author, a 58 year old male non-
drinker, with no history of folate deficiency or anaemia.
He had for many years consumed a vegetarian diet re-
plete in folate, and had never taken folate supplements.
There are no reported interferences, with any of the ana-
lytes monitored, from any medication taken by the sub-
ject. Because of a history of vitamin B12 deficiency, of
uncertain cause, the subject had been taking 1000 μgoral methylcobalamin daily for two years immediately
prior to this study. Extensive testing showed consistently
normal results for serum vitamin B12 and the two me-
tabolites, homocysteine and methylmalonic acid, at this
level of intake.The folate-deficient diet
The folate-deficient diet was a modified vegetarian version
of that used by Herbert (1962, 1963). Several variations
were made during the course of the experiment to im-
prove the balance between folate reduction and energy
maintenance. This was necessary to minimize the signifi-
cant weight loss caused by the semi-starvation diet. The
average daily dietary folate intake, during the depletion
stage, varied from 25 μg to 2 μg, or 6% to 0.5% of the rec-
ommended daily intake (RDI) of 400 μg (Institute of
Medicine, National Academy of Sciences 1998). The folate
concentration for each food item was taken from the data
provided by Food Standards Australia and New Zealand
(2011). For the last ten months of folate starvation, the
diet consisted primarily of white rice, boiled and washed
three times, flavoured with either salt or coconut and
sugar; additional energy was supplied by Gatorade and
barley sugar. Compliance with the diet was 100%.Blood sampling
Blood sample collection
Precautions were taken to ensure that consistent and valid
blood samples were received by the laboratories. Each of
the three laboratories that performed the routine bio-
chemistry and haematology tests collected their own sam-
ples, using professional phlebotomists at government-
approved collection centres. In the morning of each sam-
pling day, the blood samples were all collected within the
narrowest possible time window; usually not more than
two hours from first to last. The subject always fasted
overnight, and was well hydrated, ensuring maximum
possible consistency between samples. The phlebotomy
technique use by each collector was chosen to provide the
highest quality samples; tourniquet application was care-
fully controlled, and discard tubes were used where re-
quired. All samples were promptly transported from the
collection centre to the laboratory, cooled on ice, to avoid
deterioration.Blood sampling frequency
The frequency of routine blood sampling was adapted
according to the rate of change of the biochemical and
haematological responses. Blood samples were initially
collected weekly; this was increased to twice weekly for
the last three months of the folate depletion stage and
the first month of the recovery stage.
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Immunoassay red-cell folate
All three commercial clinical pathology laboratories were
used to assay red-cell folate, using automated immunoassay
systems. Laboratory A used the Siemens Advia Centaur;
Laboratory B used the Roche Elecsys 2010; Laboratory C
used the Beckman UniCel DxI 800.
There was a change in method for the Roche Elecsys
2010, towards the end of the folate-depletion stage (Roche
Diagnostics 2011). The change was only in the instrument
software; the hardware and reagents remained unchanged.
This modification, to the internal analyser software, sig-
nificantly reduced the sensitivity of the instrument. Several
later results were therefore reported only as “< x nmol/L”,
rather than as a numerical result, even for red-cell folate
concentrations apparently greater than 1000 nmol/L.
Immunoassay serum folate
Laboratories A and B reported serum folate using the
same systems used for red-cell folate; Laboratory C did
not report serum folate.
Folate microbiological assays
Microbiological serum and red-cell folate assays, of a
single blood sample collected on day 574, were used to
confirm severe folate depletion of the subject. The assays
were performed by the Food Science and Human Nutrition
Department, University of Florida. The procedure, based
on that described by O’Broin and Kelleher (1992), was de-
veloped by the Centers for Disease Control and Prevention
(Zhang et al. 2008).
Special precautions were taken, during collection and
transport of the blood samples, to ensure that valid sam-
ples were received by the laboratory. Serum samples
were collected in serum separator tubes, and whole
blood samples were collected in EDTA tubes. The serum
tubes were spun down at the collection centre, and all
samples were immediately transported, cooled on ice, to
the local laboratory. Aliquots of serum and whole blood
were then transferred to cryovials and frozen to −80°C.
The samples were sent, packed in dry ice, to the labora-
tory in Florida by specialized international courier. All
samples were received frozen, and in excellent condition,
then stored at −80°C until assayed.
Homocysteine
Serum total homocysteine was routinely assayed by
Laboratory A only, using the Siemens Advia Centaur im-
munoassay system.
Haemoglobin
Three clinical pathology laboratories, each equipped
with commercially available automated cell counters,
were used to monitor the haematological responses tofolate depletion. Laboratories A and C used the Sysmex
XE-2100 Automated Haematology System; Laboratory B
used the Sysmex XS-1000i haematology analyser.
Bone marrow examinations
Two bone marrow biopsies were performed by an expe-
rienced physician, and samples were forwarded to
Laboratory C for examination; the first on day 402; the
second on day 575. Whole blood, bone marrow aspirate
and trephine samples were collected. Marrow aspirate
was examined for cellularity, myelogram was performed,
and surface markers analysed. Marrow trephine was ex-
amined for normality of bone trabeculae, cellularity and
infiltration.
Red-cell folate immunoassay errors - statistical analysis
The differences in results between the three immuno-
assay methods were analysed using four graphical tech-
niques: comparison of results with lines of equality,
including confidence intervals, on an X-Y plot; difference
between results, in standard deviations, against the result
means; difference between results, in standard devia-
tions, over time; variation in results, with confidence in-
tervals, over time.
Comparison with lines of equality
This traditional technique, for comparing results be-
tween methods, provides some information but is not
considered to be as useful as the difference plot (Bland
and Altman 1986; Petersen et al. 1997; Westgard and
Hunt 1973). The red-cell folate results from one im-
munoassay system are plotted on the X axis, and results
from another are plotted on the Y axis, for each pair of
results. The results, from the two assay methods, may be
compared to confidence intervals around the line of
equality. Because the confidence intervals are derived
from the results on the X axis, with the method used to
generate those results effectively treated as a reference
method, the magnitude of errors can be overstated. The
correlation coefficient may be calculated, but a high cor-
relation does not imply agreement between results from
two immunoassay methods (Bland and Altman 1986).
Errors against means
This is the technique, for comparing differences in re-
sults from two methods, recommended by Bland and
Altman (1986). The difference within pairs of red-cell
immunoassay results, in standard deviations, is plotted
against the mean of each pair of results. This provides
information about how the difference in results for two
methods is dependent on the mean of the red-cell folate
concentration. Because the confidence intervals are de-
rived from the means of the results, the magnitude of er-
rors is less likely to be overstated.
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This a variation of the technique recommended by Bland
and Altman (1986). The difference within pairs of red-
cell immunoassay results, in standard deviations, is plot-
ted against time. This provides information about how
the difference in results for two methods is dependent
on time.
Variation over time
The red-cell results from all three immunoassay systems
are plotted, with the 95% confidence interval for each
method, against time on the same chart. This allows a
comparison of all three methods together, showing how
the differences between them depend on time.
Calculation of errors
The percentage error between results for two different
methods is calculated as:
Error %ð Þ ¼ 100  result B – result Að Þ
 maximum result A; result Bð Þ
The error, in standard deviations (SD), between two
results is calculated as:
Error SDð Þ ¼ Error %ð Þ = CVa %ð Þ
Where CVa = coefficient of analytical variation
According to RCPA (2013) and Ricos et al. (2012), for
desirable performance, CVa is calculated as:
CVa ¼ CVi = 2
Where CVi = within-subject coefficient of biological
variation
The error, in standard deviations, between two results
was therefore calculated as
Error SDð Þ ¼ ð100  ðresult B – result AÞ
 maximum ðresult A; result BÞÞ = ðCVi = 2Þ
Where CVi = 12%
The value of CVi for red-cell folate was obtained from
Ricos et al. (2012).
Results
Data availability
The data sets supporting all results are included in a
Microsoft Excel spreadsheet file, Additional file 1, con-
taining charts and tables. High-resolution images for
Figures 1 to 6 are included in a PDF file, Additional file 2,
and a Microsoft PowerPoint file, Additional file 3.
Folate immunoassays
Immunoassay serum folate
Serum folate (Figure 1C) was initially above the analyser
limit of 54 nmol/L, a presumed consequence of an initialfolate-replete diet. Serum folate responded without
delay, after commencement of the folate-deficient diet
on Day 0, rapidly falling to a stable level near the normal
lower limit of 6.8 nmol/L in 147 days. There was no
consistent fall below normal until after day 219, when it
fell slowly but consistently to reach zero on day 525.
Serum folate increased rapidly immediately after restor-
ation of the normal folate-replete diet.
Immunoassay red-cell folate
The three clinical pathology laboratories reported very sig-
nificantly different results for red-cell folate (Figure 1D).
Results from Laboratory A initially vary randomly around
1000 nmol/L, with no significant response until day 343.
There is then a decelerating fall, to below the normal
lower limit of 360 nmol/L on day 420, reaching zero folate
on day 574. Red-cell folate results from Laboratory B
show an initial concentration of 2988 nmol/L, falling
slowly but without significant delay and with initial severe
instability, reaching a minimum of 879 nmol/L on day
469. Laboratory C shows an initial red-cell folate concen-
tration of 2142 nmol/L, falling slowly but without signifi-
cant delay, with slight instability, reaching a minimum of
535 nmol/L on day 525. All three laboratories reported a
rapid increase in red-cell folate levels immediately follow-
ing resumption of the folate-replete diet.
Folate microbiological assay
The Food Science and Human Nutrition Department,
University of Florida, provided a summary report of their
results for red-cell folate and serum folate (unpublished;
copy available from this author) for samples collected on
day 574. The mean serum folate was 0.6 ± 0.09 nmol/L
(n = 8), with an inter-assay CV of 5.4% and an intra-
assay CV of 7.9%. The mean red-cell folate was
99 nmol/L, with an inter-assay CV of 12.5% and an
intra-assay CV of 7.2%. The report noted: “We have
never analyzed samples with folate concentrations as
low as these samples”.
Homocysteine
Serum total homocysteine was initially 9.9 μmol/L, vary-
ing around the recommended upper limit of 10.0 μmol/L,
but with no significant change until day 323 (Figure 1B).
The homocysteine concentration then increased expo-
nentially, with some short-term variations, to reach a
maximum of 49.3 μmol/L on day 553. Following the re-
sumption of the folate-replete diet, the serum homo-
cysteine concentration fell rapidly to 7.2 μmol/L.
Haemoglobin
Haemoglobin was within the normal range at the com-
mencement of the experiment (Figure 1A), remained
































































































Advia Centaur Elecsys 2010 UniCel DxI 800
Figure 1 Changes in analytes over time. A. Haemoglobin. B. Serum total homocysteine. C. Serum folate. D. Red-cell folate. Severe dietary folate
deficiency commenced on Day 0 (23 May 2011). The folate-replete diet, with folate supplementation, resumed on day 586 (29 December 2012),
and recovery was complete on day 772 (3 July 2013). The dotted lines in panels A, C and D are the minimum normals, and the long-dashed line
in panel A is the maximum normal, according to Bates and Lewis (2012). The dotted line in panel A is also the WHO (2011) haemoglobin
concentration for mild anaemia; the short-dashed line is the WHO concentration for moderate anaemia and the dot-dashed line is the WHO
concentration for severe anaemia. The short-dashed line in panel B is the upper limit for patients with high coronary risk factors (Stanger et al.
2004), and the long-dashed line is the upper limit in case of normal coronary risk factors (Brouwer et al. 1998). The short-dashed lines in panel
D are the low end of the reference range, or a minimum cut-off value, as quoted by each testing laboratory.
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reaching a minimum near day 588, two days after re-
sumption of the folate-replete diet. Haemoglobin then
increased without further delay, returning to the initial
level on day 772.
Bone marrow examinations
The results of the first bone marrow examination were all
normal except for mildly decreased iron stores, whereas
those for the second clearly demonstrated megaloblastic
anaemia. Cellularity of the aspirate was moderately in-
creased, erythropoiesis showed moderately dyserythro-
poietic features, including megaloblastic changes and poor
hemoglobinization. Some hypersegmented neutrophils
were present but lymphocytes were normal. Plasma cells
were normal and megakaryocytes were within normal
limits; there was an occasional very large form with bi-
zarre nuclear morphology. Iron stores were normal; an
occasional ring sideroblast was present. Bone marrowsurface markers were all normal. Trephine biopsy marrow
was hypocellular in one half and normal in the other; tra-
beculae appeared normal. There was no evidence of ma-
lignant infiltration.
Red-cell folate immunoassay performance
Siemens Advia Centaur
Laboratory A, using the Siemens Advia Centaur im-
munoassay system, consistently reported red-cell folate
concentrations below the reference level defined by
Bates and Lewis (2012) (Figure 2A), after day 413, fol-
lowing folate depletion. Laboratory A also consistently
reported red-cell folate concentrations very significantly
below their own minimum level (Figure 2B), after day
357. The red-cell folate concentration reported by the
Siemens Advia Centaur was the only one that was con-
sistent with the single-point result reported by the Food














A Ratio red-cell folate to reference minimum















B Ratio red-cell folate to laboratory minimum
Advia Centaur Elecsys 2010 UniCel DxI 800
Figure 2 Ratio of reported red-cell folate to lower limit over time. A. Ratio red-cell folate to reference minimum. B. Ratio red-cell folate to
laboratory minimum. The reference minimum, dotted line, in panel A is the red-cell folate normal lower limit according to Bates and Lewis (2012). The
laboratory minimum, dotted line, in panel B is the low end of the reference range, or a minimum cut-off value, quoted by each laboratory.
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Laboratory B, using the Roche Elecsys 2010, never re-
ported red-cell folate concentrations below the reference
level defined by Bates and Lewis (2012) (Figure 2A).
Laboratory B only once reported red-cell folate concen-
trations slightly below their own initial minimum level
(Figure 2B). After their minimum normal level was in-
creased very significantly, following the change in method
towards the end of the depletion stage, the Roche Elecsys
2010 reported increasing red-cell folate concentrations
that were initially below their new minimum level. Be-
cause of the change in method, the Roche Elecsys 2010
was not always able to report a numerical result for red-
cell folate concentration. The Roche Elecsys 2010 result
for the previous week was far higher than the single-point
result reported by the Food Science and Human Nutrition
Department, University of Florida.Beckman UniCel DxI 800
Laboratory C, using the Beckman UniCel DxI 800, never
reported red-cell folate concentrations below the refer-
ence level defined by Bates and Lewis (2012) (Figure 2A).
Laboratory C consistently reported red-cell folate con-
centrations significantly below their own minimum level,
following folate depletion (Figure 2B), after day 308. The
red-cell folate concentration reported by the Beckman
UniCel DxI 800 was far higher than the single-point re-
sult reported by the Food Science and Human Nutrition
Department, University of Florida.Red-cell folate immunoassay error analysis
Comparison with lines of equality
The results from all three combinations of red-cell folate
immunoassay methods were compared to the lines of
equality and confidence intervals (Figure 3). Of the 85results comparing the Siemens Advia Centaur and the
Roche Elecsys 2010, none were within the 99.9% confi-
dence interval (Figure 3A). Of the 91 results comparing
the Siemens Advia Centaur and the Beckman UniCel
DxI 800, 17 were within the 99.9% confidence interval
(Figure 3B). Of the 83 results comparing the Beckman
UniCel DxI 800 and the Roche Elecsys 2010, 16 were
within the 99.9% confidence interval (Figure 3C).
The results comparing the Siemens Advia Centaur and
the Beckman UniCel DxI 800 were weakly correlated,
with a correlation coefficient of 0.75. The results com-
paring the Siemens Advia Centaur and the Beckman
UniCel DxI 800 were also weakly correlated, with a cor-
relation coefficient of 0.73. There was stronger correl-
ation between the results from the Beckman UniCel DxI
800 and the Roche Elecsys 2010, with a correlation coef-
ficient of 0.91.Errors against mean
The errors, in standard deviations, between results from
all three combinations of red-cell folate immunoassay
methods were plotted against the mean (Figure 4). Of
the 85 results comparing the Siemens Advia Centaur
and the Roche Elecsys 2010, two were within the 99.9%
confidence interval (Figure 4A). Of the 91 results com-
paring the Siemens Advia Centaur and the Beckman
UniCel DxI 800, 22 were within the 99.9% confidence
interval (Figure 4B). Of the 83 results comparing the
Beckman UniCel DxI 800 and the Roche Elecsys 2010, 37
were within the 99.9% confidence interval (Figure 4C).Errors over time
The errors, in standard deviations, between results from
all three combinations of red-cell folate immunoassay
methods were plotted against time (Figure 5). The

























Advia Centaur red-cell folate (nmol/L)
A Elecsys 2010 vs Advia Centaur



























Advia centaur red-cell folate (nmol/L)
B UniCel DxI 800 vs Advia Centaur

























UniCel DxI 800 red-cell folate (nmol/L)
C Elecsys 2010 vs UniCel DxI 80
Figure 3 Comparison of red-cell folate immunoassay results. A. Elecsys 2010 vs Advia Centaur. B. Unicel Dxl 800 vs Advia Centaur. C. Elecsys
2010 vs Unicel Dxl 800. The dotted lines are for equality, or zero error. The dashed lines are the 95% confidence interval, and the dot-dashed lines
are the 99.9% confidence interval. The solid lines are the linear regression lines.
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and the Roche Elecsys 2010 was 16 standard deviations,
on day 504 (Figure 5A). The maximum difference between
the Siemens Advia Centaur and the Beckman UniCel
DxI 800 was 17 standard deviations, on days 575 and
584 (Figure 5B). The maximum difference between the
Roche Elecsys 2010 and the Beckman UniCel DxI 800
was nine standard deviations, on day 22 (Figure 5C).Variation over time, with error limits
The results from all three red-cell folate immunoassay
methods, with the 95% confidence intervals, were plot-
ted against time (Figure 6). None of the results from
Laboratory A were initially within the 95% confidence
interval of the results from either of the other laborator-
ies. The results then tend to converge, with 10 out of 91
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C Elecsys 2010 - UniCel DxI 800
Figure 4 Red-cell folate immunoassay errors against mean. A. Elecsys 2010 - Advia Centaur. B. Unicel Dxl 800 - Advia Centaur. C. Elecsys
2010 - Unicel Dxl 800. The dotted lines are for equality, or zero error. The dashed lines are the 95% confidence interval, and the dot-dashed lines
are the 99.9% confidence interval.
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http://www.springerplus.com/content/3/1/441confidence interval, but none of the 85 results from Labora-
tories A and B being within the 95% confidence interval.
The results rapidly diverge after day 343, with no results
from Laboratory A, and either of the other two laboratories,
being within the 95% confidence interval after day 378.
Discussion
The fall in haemoglobin concentration, to a level well
below that defined by World Health Organization (2011)for moderate anaemia, and the finding of megaloblastic
changes and poor haemoglobinisation in the second
bone marrow examination, confirm the development of
megaloblastic anaemia. The very low serum and red-cell
folate concentrations, reported by the University of
Florida, confirm that the subject was severely depleted of
folate. The rise in serum total homocysteine concentra-
tion, to well above the maximum normal level, confirms































































C Elecsys 2010 - UniCel DxI 800
Figure 5 Red-cell folate immunoassay errors over time. A. Elecsys 2010 - Advia Centaur. B. Unicel Dxl 800 - Advia Centaur. C. Elecsys 2010 -
Unicel Dxl 800. The dotted lines are for equality, or zero error. The dashed lines are the 95% confidence interval, and the dot-dashed lines are the
99.9% confidence interval.
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http://www.springerplus.com/content/3/1/441Only one of the three laboratories reported red-cell
folate results that were consistent with the evidence for
folate deficiency, as defined by the reference level of
Bates and Lewis (2012). Laboratory A, using the Siemens
Advia Centaur immunoassay system, consistently re-
ported red-cell folate concentrations very significantly
below the reference level.
Two of the three laboratories reported red-cell folate
results that were consistent with the evidence for folatedeficiency, as defined by their own minimum levels. La-
boratory A, using the Siemens Advia Centaur, and Labora-
tory C, using the Beckman UniCel DxI 800, consistently
reported red-cell folate concentrations significantly below
their own minimum levels, following folate depletion. La-
boratory B, using the Roche Elecsys 2010, reported red-cell
folate concentrations below their own minimum level only
after that minimum level was significantly increased by the






















Elecsys 2010 UniCel DxI 800 Advia Centaur
Figure 6 Red-cell folate and error limits over time. The solid lines are the reported results. The shaded areas are the individual 95% confidence
intervals for each measurement.
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reported by the three laboratories, varied with time and
folate concentration. The differences were greatest, up
to 17 standard deviations, between the Siemens Advia
Centaur and each of the Roche Elecsys 2010 and the
Beckman UniCel DxI 800. Less than a quarter of the re-
sults for the Siemens Advia Centaur, and those from
each of the other two systems, were within a 99.9% con-
fidence interval. Less than half of the results from the
Roche Elecsys 2010 and the Beckman UniCel DxI 800
were within a 99.9% confidence interval.
Potential explanations for immunoassay differences
Immunoassay interference
A potential explanation for the very significant differences
in results between the three immunoassay methods is im-
munoassay interference (Selby 1999; Kricka 2000; Tate
and Ward 2004). Antibodies in the subject’s blood can
compete with antibodies used in the immunoassay kits.
The type of antibody used, and the extent of warnings
provided, varies between the immunoassay kit manufac-
turers (Siemens 2004; Roche Diagnostics 2011; BeckmanCoulter 2008). The absence of any significant difference in
results between the Siemens Advia Centaur and the Roche
Elecsys 2010, for serum folate, suggests that any interfer-
ence cannot be caused by antibodies in the serum.Sample preparation
The most likely explanation for the very significant differ-
ences in results, between the three immunoassay methods,
is difference in sample preparation (Gilois et al. 1990;
Wright et al. 1998, 2000; Netteland and Bakke 1977;
Omer 1969). All three immunoassay systems use dif-
ferent methods of sample preparation (Siemens 2004;
Roche Diagnostics 2011; Beckman Coulter 2008). There
is a high correlation between red-cell folate results from
the Roche Elecsys 2010 and the Beckman UniCel DxI
800, but not between those systems and the Siemens
Advia Centaur. This, together with the similarity in re-
sults between the Siemens Advia Centaur and the Roche
Elecsys 2010 for serum folate, suggest differences in
sample preparation as the most likely cause for the very
significantly different results for red-cell folate.
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Qualitative response to folate depletion
Why did the Roche Elecsys 2010 and the Beckman
UniCel DxI 800 report significantly falling red-cell folate
concentrations in the first 330 days, whereas the
Siemens Advia Centaur reported no change in that
period (Figures 1D, 2 and 6)? This question needs to be
considered in the context of the observation that the
Siemens Advia Centaur was the only immunoassay
method to report results that were consistent with the
microbiological assay; it was also the only immunoassay
to report folate deficiency, as defined by the reference
level of Bates and Lewis (2012).
Change in method for the Roche Elecsys 2010
Why was there a change in sensitivity of the Roche
Elecsys 2010, towards the end of the folate-depletion
stage? This question needs to be considered in the con-
text of the fact that the change was in the instrument
software only, with the hardware and reagents un-
changed. The effect of the change was to very signifi-
cantly increase the minimum reportable concentration
of red-cell folate, preventing meaningful reporting of
some of the later results.
Change in minimum of reference range for the Roche
Elecsys 2010
Why was there a very significant increase in the mini-
mum of the reference range for the Roche Elecsys 2010,
towards the end of the folate-depletion stage (Figure 1D)?
Without this change, this immunoassay would not have
reported any folate deficiency, as defined by the labora-
tory’s own reference level, even when megaloblastic an-
aemia was most severe.
Limitations of the experiment
Number of subjects
For ethical reasons, a longitudinal experiment designed
to produce megaloblastic anaemia can only be per-
formed by means of self-experimentation on a single
subject. It is therefore not possible to produce compara-
tive longitudinal red-cell folate immunoassay data for a
large group of subjects. The results for this single subject
do provide unique longitudinal data that is consistent
with the two published comparison studies for the three
immunoassays used in this experiment (Callen 2010;
Owen and Roberts 2003).
Number of laboratories
In an ideal world, to eliminate individual laboratory
error, it would be desirable to have samples tested by
more than one laboratory utilizing each immunoassay
method. This was not practical because of logistical
problems, including the need to draw excessive volumesof blood from the subject on each sampling day. With
modern automated immunoassay systems, with use of
pre-packaged reagent kits, the likelihood of significant
individual laboratory error has been reduced. Taking
into account the strict quality control procedures re-
quired, and the very large number of sampling days over
such a long time span, it is unlikely that the differences
can be explained by individual laboratory error.
Conclusions
Comparative longitudinal data from clinical pathology
laboratories, produced during experimental folate defi-
ciency, have exposed very significant differences in results
between commercial red-cell folate immunoassays. One
immunoassay, the Roche Elecsys 2010, failed to detect
overt megaloblastic anaemia of severe folate deficiency.
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